Lazard Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98K | Buy |
|
|||||
|
2025
Q1 | $0 | Sell |
|
|||||
|
2024
Q4 | $5K | Sell |
|
|||||
|
2024
Q3 | $10K | Sell |
|
|||||
|
2024
Q2 | $22K | Buy |
|
|||||
|
2024
Q1 | $2K | Sell |
|
|||||
|
2023
Q4 | $1K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $27K | Hold |
|
|||||
|
2022
Q1 | $40K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $54K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $8K | Sell |
|
|||||
|
2020
Q1 | $380K | Hold |
|
|||||
|
2019
Q4 | $412K | Sell |
|
|||||
|
2019
Q3 | $377K | Hold |
|
|||||
|
2019
Q2 | $574K | Hold |
|
|||||
|
2019
Q1 | $550K | Buy |
|
|||||
|
2018
Q4 | $591K | Hold |
|
|||||
|
2018
Q3 | $725K | Buy |
|